Showing results (101-110 of 147) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|January 6, 2020
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosisJohn Foley, Cynthia Carrillo-Infante, Jonathan Smith, et al.Plos Currents|December 24, 2009
Rapid development of an efficacious swine vaccine for novel H1N1Ryan Vander Veen, Kurt Kamrud, Mark Mogler, et al.Clinical and Translational Radiation Oncology|May 6, 2020
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancerFinbar Slevin, Samantha Hodgson, Sree Lakshmi Rodda, et al.Pediatric Transplantation|March 22, 2020
Review of interactions between high-risk pediatric heart transplant recipients and marginal donors including utilization of risk score modelsJeffrey G Gossett, Shahnawaz Amdani, Sanjeev Khulbey, et al.Journal of Virology|April 29, 2005
Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteinsAndrea Bertolotti-Ciarlet, Jonathan Smith, Karin Strecker, et al.Plos Neglected Tropical Diseases|March 12, 2021
Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virusLo Vang, Christopher S Morello, Jason Mendy, et al.Emerging Infectious Diseases|April 3, 2002
Eastern equine encephalomyelitis virus infection in a horse from CaliforniaRobert P Franklin, Hailu Kinde, Michele T Jay, et al.Cardiovascular and Interventional Radiology|November 15, 2022
A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER)Tze Min Wah, Maciej Pech, Maximilian Thormann, et al.Journal of Virology|May 28, 2010
In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAsKurt I Kamrud, V McNeil Coffield, Gary Owens, et al.Clinical and Translational Radiation Oncology|November 9, 2019
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapyFinbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.Pageof 15